Global Therapeutic Proteins and Oral Vaccines Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 137
Published Date: 04 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Therapeutic Proteins and Oral Vaccines market size was valued at USD 438.3 million in 2023 and is forecast to a readjusted size of USD 643.8 million by 2030 with a CAGR of 5.6% during review period.
Therapeutic proteins are engineered in the laboratory for pharmaceutical use. They include non-covalent binders, enzymes and albumin and therefore have a wide range of treatment applications. Oral vaccines are biologically prepared products, which provide active acquired immunity to diseases. There are currently oral vaccines targeting cholera, polio, rotavirus, smallpox and yellow fever, among others. Oral vaccines comprise an agent resembling the disease-causing microorganism, such as a live attenuated or killed viral particle or the micro-organisms toxins or surface proteins.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Therapeutic Proteins and Oral Vaccines industry chain, the market status of Hospital Pharmacies (Therapeutic Proteins, Oral Vaccines), Retail Pharmacies (Therapeutic Proteins, Oral Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Therapeutic Proteins and Oral Vaccines.
Regionally, the report analyzes the Therapeutic Proteins and Oral Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Therapeutic Proteins and Oral Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Therapeutic Proteins and Oral Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Therapeutic Proteins and Oral Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Therapeutic Proteins, Oral Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Therapeutic Proteins and Oral Vaccines market.
Regional Analysis: The report involves examining the Therapeutic Proteins and Oral Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Therapeutic Proteins and Oral Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Therapeutic Proteins and Oral Vaccines:
Company Analysis: Report covers individual Therapeutic Proteins and Oral Vaccines players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Therapeutic Proteins and Oral Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Therapeutic Proteins and Oral Vaccines. It assesses the current state, advancements, and potential future developments in Therapeutic Proteins and Oral Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Therapeutic Proteins and Oral Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Therapeutic Proteins and Oral Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Therapeutic Proteins
Oral Vaccines
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
Abbott
Amgen
Biogen
Eli Lilly and Company
Roche
Johnson and Johnson
Merck
Novo Nordisk
Pfizer
Sanofi
Serum Institute of India
Emergent Biosolutions
TransAlgae
MigVax
Lumen Bioscience
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Therapeutic Proteins and Oral Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Therapeutic Proteins and Oral Vaccines, with revenue, gross margin and global market share of Therapeutic Proteins and Oral Vaccines from 2019 to 2024.
Chapter 3, the Therapeutic Proteins and Oral Vaccines competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Therapeutic Proteins and Oral Vaccines market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Therapeutic Proteins and Oral Vaccines.
Chapter 13, to describe Therapeutic Proteins and Oral Vaccines research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Therapeutic Proteins and Oral Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Therapeutic Proteins and Oral Vaccines by Type
1.3.1 Overview: Global Therapeutic Proteins and Oral Vaccines Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Type in 2023
1.3.3 Therapeutic Proteins
1.3.4 Oral Vaccines
1.4 Global Therapeutic Proteins and Oral Vaccines Market by Application
1.4.1 Overview: Global Therapeutic Proteins and Oral Vaccines Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Therapeutic Proteins and Oral Vaccines Market Size & Forecast
1.6 Global Therapeutic Proteins and Oral Vaccines Market Size and Forecast by Region
1.6.1 Global Therapeutic Proteins and Oral Vaccines Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Therapeutic Proteins and Oral Vaccines Market Size by Region, (2019-2030)
1.6.3 North America Therapeutic Proteins and Oral Vaccines Market Size and Prospect (2019-2030)
1.6.4 Europe Therapeutic Proteins and Oral Vaccines Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size and Prospect (2019-2030)
1.6.6 South America Therapeutic Proteins and Oral Vaccines Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size and Prospect (2019-2030)
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Therapeutic Proteins and Oral Vaccines Product and Solutions
2.1.4 Abbott Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Therapeutic Proteins and Oral Vaccines Product and Solutions
2.2.4 Amgen Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Amgen Recent Developments and Future Plans
2.3 Biogen
2.3.1 Biogen Details
2.3.2 Biogen Major Business
2.3.3 Biogen Therapeutic Proteins and Oral Vaccines Product and Solutions
2.3.4 Biogen Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Biogen Recent Developments and Future Plans
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business
2.4.3 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product and Solutions
2.4.4 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Eli Lilly and Company Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Therapeutic Proteins and Oral Vaccines Product and Solutions
2.5.4 Roche Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Roche Recent Developments and Future Plans
2.6 Johnson and Johnson
2.6.1 Johnson and Johnson Details
2.6.2 Johnson and Johnson Major Business
2.6.3 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product and Solutions
2.6.4 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Johnson and Johnson Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Therapeutic Proteins and Oral Vaccines Product and Solutions
2.7.4 Merck Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Merck Recent Developments and Future Plans
2.8 Novo Nordisk
2.8.1 Novo Nordisk Details
2.8.2 Novo Nordisk Major Business
2.8.3 Novo Nordisk Therapeutic Proteins and Oral Vaccines Product and Solutions
2.8.4 Novo Nordisk Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Novo Nordisk Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Therapeutic Proteins and Oral Vaccines Product and Solutions
2.9.4 Pfizer Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Pfizer Recent Developments and Future Plans
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business
2.10.3 Sanofi Therapeutic Proteins and Oral Vaccines Product and Solutions
2.10.4 Sanofi Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Sanofi Recent Developments and Future Plans
2.11 Serum Institute of India
2.11.1 Serum Institute of India Details
2.11.2 Serum Institute of India Major Business
2.11.3 Serum Institute of India Therapeutic Proteins and Oral Vaccines Product and Solutions
2.11.4 Serum Institute of India Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Serum Institute of India Recent Developments and Future Plans
2.12 Emergent Biosolutions
2.12.1 Emergent Biosolutions Details
2.12.2 Emergent Biosolutions Major Business
2.12.3 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product and Solutions
2.12.4 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Emergent Biosolutions Recent Developments and Future Plans
2.13 TransAlgae
2.13.1 TransAlgae Details
2.13.2 TransAlgae Major Business
2.13.3 TransAlgae Therapeutic Proteins and Oral Vaccines Product and Solutions
2.13.4 TransAlgae Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 TransAlgae Recent Developments and Future Plans
2.14 MigVax
2.14.1 MigVax Details
2.14.2 MigVax Major Business
2.14.3 MigVax Therapeutic Proteins and Oral Vaccines Product and Solutions
2.14.4 MigVax Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 MigVax Recent Developments and Future Plans
2.15 Lumen Bioscience
2.15.1 Lumen Bioscience Details
2.15.2 Lumen Bioscience Major Business
2.15.3 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product and Solutions
2.15.4 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Lumen Bioscience Recent Developments and Future Plans
3.1 Global Therapeutic Proteins and Oral Vaccines Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Therapeutic Proteins and Oral Vaccines by Company Revenue
3.2.2 Top 3 Therapeutic Proteins and Oral Vaccines Players Market Share in 2023
3.2.3 Top 6 Therapeutic Proteins and Oral Vaccines Players Market Share in 2023
3.3 Therapeutic Proteins and Oral Vaccines Market: Overall Company Footprint Analysis
3.3.1 Therapeutic Proteins and Oral Vaccines Market: Region Footprint
3.3.2 Therapeutic Proteins and Oral Vaccines Market: Company Product Type Footprint
3.3.3 Therapeutic Proteins and Oral Vaccines Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Therapeutic Proteins and Oral Vaccines Consumption Value and Market Share by Type (2019-2024)
4.2 Global Therapeutic Proteins and Oral Vaccines Market Forecast by Type (2025-2030)
5.1 Global Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Application (2019-2024)
5.2 Global Therapeutic Proteins and Oral Vaccines Market Forecast by Application (2025-2030)
6.1 North America Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2019-2030)
6.2 North America Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2019-2030)
6.3 North America Therapeutic Proteins and Oral Vaccines Market Size by Country
6.3.1 North America Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2019-2030)
6.3.2 United States Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
6.3.3 Canada Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
6.3.4 Mexico Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
7.1 Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2019-2030)
7.2 Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2019-2030)
7.3 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country
7.3.1 Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2019-2030)
7.3.2 Germany Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
7.3.3 France Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
7.3.5 Russia Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
7.3.6 Italy Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region
8.3.1 Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Region (2019-2030)
8.3.2 China Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
8.3.3 Japan Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
8.3.4 South Korea Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
8.3.5 India Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
8.3.7 Australia Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
9.1 South America Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2019-2030)
9.2 South America Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2019-2030)
9.3 South America Therapeutic Proteins and Oral Vaccines Market Size by Country
9.3.1 South America Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2019-2030)
9.3.2 Brazil Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
9.3.3 Argentina Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country
10.3.1 Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2019-2030)
10.3.2 Turkey Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
10.3.4 UAE Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2019-2030)
11.1 Therapeutic Proteins and Oral Vaccines Market Drivers
11.2 Therapeutic Proteins and Oral Vaccines Market Restraints
11.3 Therapeutic Proteins and Oral Vaccines Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Therapeutic Proteins and Oral Vaccines Industry Chain
12.2 Therapeutic Proteins and Oral Vaccines Upstream Analysis
12.3 Therapeutic Proteins and Oral Vaccines Midstream Analysis
12.4 Therapeutic Proteins and Oral Vaccines Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Therapeutic Proteins and Oral Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Therapeutic Proteins and Oral Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Therapeutic Proteins and Oral Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Therapeutic Proteins and Oral Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Abbott Company Information, Head Office, and Major Competitors
Table 6. Abbott Major Business
Table 7. Abbott Therapeutic Proteins and Oral Vaccines Product and Solutions
Table 8. Abbott Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Abbott Recent Developments and Future Plans
Table 10. Amgen Company Information, Head Office, and Major Competitors
Table 11. Amgen Major Business
Table 12. Amgen Therapeutic Proteins and Oral Vaccines Product and Solutions
Table 13. Amgen Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Amgen Recent Developments and Future Plans
Table 15. Biogen Company Information, Head Office, and Major Competitors
Table 16. Biogen Major Business
Table 17. Biogen Therapeutic Proteins and Oral Vaccines Product and Solutions
Table 18. Biogen Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Biogen Recent Developments and Future Plans
Table 20. Eli Lilly and Company Company Information, Head Office, and Major Competitors
Table 21. Eli Lilly and Company Major Business
Table 22. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product and Solutions
Table 23. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Eli Lilly and Company Recent Developments and Future Plans
Table 25. Roche Company Information, Head Office, and Major Competitors
Table 26. Roche Major Business
Table 27. Roche Therapeutic Proteins and Oral Vaccines Product and Solutions
Table 28. Roche Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Roche Recent Developments and Future Plans
Table 30. Johnson and Johnson Company Information, Head Office, and Major Competitors
Table 31. Johnson and Johnson Major Business
Table 32. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product and Solutions
Table 33. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Johnson and Johnson Recent Developments and Future Plans
Table 35. Merck Company Information, Head Office, and Major Competitors
Table 36. Merck Major Business
Table 37. Merck Therapeutic Proteins and Oral Vaccines Product and Solutions
Table 38. Merck Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Merck Recent Developments and Future Plans
Table 40. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 41. Novo Nordisk Major Business
Table 42. Novo Nordisk Therapeutic Proteins and Oral Vaccines Product and Solutions
Table 43. Novo Nordisk Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Novo Nordisk Recent Developments and Future Plans
Table 45. Pfizer Company Information, Head Office, and Major Competitors
Table 46. Pfizer Major Business
Table 47. Pfizer Therapeutic Proteins and Oral Vaccines Product and Solutions
Table 48. Pfizer Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Pfizer Recent Developments and Future Plans
Table 50. Sanofi Company Information, Head Office, and Major Competitors
Table 51. Sanofi Major Business
Table 52. Sanofi Therapeutic Proteins and Oral Vaccines Product and Solutions
Table 53. Sanofi Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Sanofi Recent Developments and Future Plans
Table 55. Serum Institute of India Company Information, Head Office, and Major Competitors
Table 56. Serum Institute of India Major Business
Table 57. Serum Institute of India Therapeutic Proteins and Oral Vaccines Product and Solutions
Table 58. Serum Institute of India Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Serum Institute of India Recent Developments and Future Plans
Table 60. Emergent Biosolutions Company Information, Head Office, and Major Competitors
Table 61. Emergent Biosolutions Major Business
Table 62. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product and Solutions
Table 63. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Emergent Biosolutions Recent Developments and Future Plans
Table 65. TransAlgae Company Information, Head Office, and Major Competitors
Table 66. TransAlgae Major Business
Table 67. TransAlgae Therapeutic Proteins and Oral Vaccines Product and Solutions
Table 68. TransAlgae Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. TransAlgae Recent Developments and Future Plans
Table 70. MigVax Company Information, Head Office, and Major Competitors
Table 71. MigVax Major Business
Table 72. MigVax Therapeutic Proteins and Oral Vaccines Product and Solutions
Table 73. MigVax Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. MigVax Recent Developments and Future Plans
Table 75. Lumen Bioscience Company Information, Head Office, and Major Competitors
Table 76. Lumen Bioscience Major Business
Table 77. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product and Solutions
Table 78. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Lumen Bioscience Recent Developments and Future Plans
Table 80. Global Therapeutic Proteins and Oral Vaccines Revenue (USD Million) by Players (2019-2024)
Table 81. Global Therapeutic Proteins and Oral Vaccines Revenue Share by Players (2019-2024)
Table 82. Breakdown of Therapeutic Proteins and Oral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Therapeutic Proteins and Oral Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 84. Head Office of Key Therapeutic Proteins and Oral Vaccines Players
Table 85. Therapeutic Proteins and Oral Vaccines Market: Company Product Type Footprint
Table 86. Therapeutic Proteins and Oral Vaccines Market: Company Product Application Footprint
Table 87. Therapeutic Proteins and Oral Vaccines New Market Entrants and Barriers to Market Entry
Table 88. Therapeutic Proteins and Oral Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Therapeutic Proteins and Oral Vaccines Consumption Value (USD Million) by Type (2019-2024)
Table 90. Global Therapeutic Proteins and Oral Vaccines Consumption Value Share by Type (2019-2024)
Table 91. Global Therapeutic Proteins and Oral Vaccines Consumption Value Forecast by Type (2025-2030)
Table 92. Global Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2019-2024)
Table 93. Global Therapeutic Proteins and Oral Vaccines Consumption Value Forecast by Application (2025-2030)
Table 94. North America Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 95. North America Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 96. North America Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 97. North America Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 98. North America Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 99. North America Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 107. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 108. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 109. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 110. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 111. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 112. South America Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 113. South America Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 114. South America Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 115. South America Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 116. South America Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 119. Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 120. Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 121. Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 122. Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 123. Middle East & Africa Therapeutic Proteins and Oral Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 124. Therapeutic Proteins and Oral Vaccines Raw Material
Table 125. Key Suppliers of Therapeutic Proteins and Oral Vaccines Raw Materials
List of Figures
Figure 1. Therapeutic Proteins and Oral Vaccines Picture
Figure 2. Global Therapeutic Proteins and Oral Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Therapeutic Proteins
Figure 5. Oral Vaccines
Figure 6. Global Therapeutic Proteins and Oral Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Application in 2023
Figure 8. Hospital Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Online Pharmacies Picture
Figure 11. Global Therapeutic Proteins and Oral Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Therapeutic Proteins and Oral Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Therapeutic Proteins and Oral Vaccines Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Region in 2023
Figure 16. North America Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Therapeutic Proteins and Oral Vaccines Revenue Share by Players in 2023
Figure 22. Therapeutic Proteins and Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Therapeutic Proteins and Oral Vaccines Market Share in 2023
Figure 24. Global Top 6 Players Therapeutic Proteins and Oral Vaccines Market Share in 2023
Figure 25. Global Therapeutic Proteins and Oral Vaccines Consumption Value Share by Type (2019-2024)
Figure 26. Global Therapeutic Proteins and Oral Vaccines Market Share Forecast by Type (2025-2030)
Figure 27. Global Therapeutic Proteins and Oral Vaccines Consumption Value Share by Application (2019-2024)
Figure 28. Global Therapeutic Proteins and Oral Vaccines Market Share Forecast by Application (2025-2030)
Figure 29. North America Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 39. France Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 46. China Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 49. India Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Therapeutic Proteins and Oral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 63. Therapeutic Proteins and Oral Vaccines Market Drivers
Figure 64. Therapeutic Proteins and Oral Vaccines Market Restraints
Figure 65. Therapeutic Proteins and Oral Vaccines Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Therapeutic Proteins and Oral Vaccines in 2023
Figure 68. Manufacturing Process Analysis of Therapeutic Proteins and Oral Vaccines
Figure 69. Therapeutic Proteins and Oral Vaccines Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Abbott Amgen Biogen Eli Lilly and Company Roche Johnson and Johnson Merck Novo Nordisk Pfizer Sanofi Serum Institute of India Emergent Biosolutions TransAlgae MigVax Lumen Bioscience
Related Reports
23 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
